갈근 함유탕제의 혈당 강하 효과 = Effectiveness of Herbal Medicines Containing Kudzu Root as a Principal Ingredient in Patients with Diabetes Mellitus

다국어 초록 (Multilingual Abstract)

Background : Puerarin, the main component of kudzu root, has been shown to lowerblood glucose levels in vivo and in vitro. However, no clinical trials were performed in diabeticpatients. The purpose of this study was to determine whether kudzu root lowers blood glucose orhemoglobin A1c in diabetic patients.
Methods : We performed a retrospective study to evaluate whether the use of daily herbal medicineincluding kudzu root with conventional therapy lowers fasting blood glucose, as compared to convensigniftionaltherapy alone. 65 patients with diabetes were included in the study. 20 patients consumed 32-48 g of kudzu root extract daily for at least 20 days (median 34 days) with conventional therapy, and45 patients received conventional diabetic care alone. Fasting blood glucose level was obtained atbaseline and after the administration of herbal medicine. Hemoglobin A1c, cholesterol profiles[LDL(Low-density lipoprotein), HDL(High-density lipoprotein, TG(Triglyceride)] and AST(Aspartatetransaminase), ALT(Alanine transaminase) were measured.
Results : The difference between basal and index day fasting glucose level was 14.1 mg/dL (±24.65,p= 0.011) in the kudzu root group was statistically significant. Hemoglobin A1c data were obtainedfrom 27 participants and there was a significant improvement in both, the kudzu root treatmentgroup and the control group, with p values of 0.004 and 0.022, respectively. Cholesterol profiles andliver enzymes did not reveal significant changes.
Conclusion : The study findings suggested that kudzu root intake might help to lower serum fastingblood glucose levels in diabetic patients when combined with conventional therapy.

참고문헌 (Reference)

1 Sheepers A., "glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function" 28 (28): 364-371, 2004

2 Zheng P., "Therapeutic effect of puerarin on non-alcoholic rat fatty liver by improving leptin signal transduction through JAK2/STAT3 pathways" 69-83, 2009

3 Xu M., "The study of antimetabolic syndrome effect of puerarin in vitro" 77 (77): 3183-3196, 2005

4 Yan B., "The antidepressant effect of ethanol extract of radix puerariae in mice exposed to cerebral ischaemia reperfusion" 78 (78): 319-325, 2004

5 "The Statistics Korea : Statistics of Cause of Death in Korea"

6 Jiao Zheng, "The Effects of Puerarin on CYP2D6 and CYP1A2 Activities In Vivo" 대한약학회 33 (33): 243-246, 2010

7 Cheng J., "Stimulatory effect of phenylephrine on secretion of beta-endorphin from rat adrenal medulla in vitro" 93 (93): 31-35, 2001

8 Qicheng F, "Some current study and research approaches relating to the use of plants in the traditional Chinese medicine" 2 (2): 57-63, 1980

9 Shiyovich A, "Sitting and cardiovascular morbidity and mortality" 152 (152): 43-48, 2013

10 Sivaprasad S., "Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective" 57 : 347-370, 2012

11 Chiarelli F, "Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives" 4 (4): 297-304, 2008

12 Bradley R., "Naturopathic medicine and type 2 diabetes: A retrospective analysis from an academic clinic" 11 (11): 30-39, 2006

13 "National Center for Complementary and Alternative Medicine (NCCAM)"

14 Chen W., "Mediation of beta-endorphin by isoflavone puerarin to lower plasma glucose in streptozotocininduced diabetic rats" 70 (70): 113-116, 2004

15 Lee J., "Longevity and Life Preservation in Oriental Medicine" Donguisusebowon 1894

16 Kim N., "Liver enzyme abnormalities during concurrent use of herbal and conventional medicines in Korea: A retrospective study" ELSEVIER GMBH 18 (18): 1208-1213, 2011

17 Meier Y., "Incidence of drug-induced liver injury in medical inpatients" 61 (61): 135-143, 2005

18 Hu Z., "Herb-drug interactions: a literature review" 65 (65): 1239-1282, 2005

19 Okoro C, "Has the use of complementary and alternative medicine therapies by U.S. adults with chronic disease-related functional limitations changed from 2002 to 2007" 19 (19): 217-223, 2013

20 Song C., "Effects of puerarin on plasma membrane GLUT4 content in skeletal muscle from insulin-resistant Sptague-Dawley rats under insulin stimulation" 29 (29): 172-175, 2004

21 Yi S., "Effects of Angelicaetenuissima radix, Angelicaedahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteers" 105 (105): 249-256, 2009

22 Wang C., "Diabetes and cardiovascular disease: changing the focus from glycemic control to improving longterm survival" 110 (110): 58-68, 2012

23 Bradley R, "Description of clinical risk factor changes during naturopathic care for type 2 diabetes" 15 (15): 633-638, 2009

24 Benichou C, "Criteria of drug-induced liver disorders-report of an international consensus meeting" 11 (11): 272-276, 1990

25 Guerra M, "Comparison between chinese medical herb Puerarialobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism" 67 (67): 2997-3006, 2000

26 Peng N., "Chronic dietary kudzu isoflavones improve components of metabolic syn-drome in stroke-prone spontaneously hypertensive rats" 57 (57): 7268-7273, 2009

27 Garrow D, "Association between complementary and alternative medicine use, preventive care practice, and use of conventional medical services among adults with diabetes" 29 (29): 15-19, 2006

28 Hsu F., "Anti hyperglycemic effect of puerarin in streptozotocin-induced diabetic rats" 66 (66): 788-792, 2003